The mechanisms of therapeutic effects of tPBM are stimulation of the brain drainage system, which improves brain immunity through a decrease in the level of inflammatory factor IFN-γ, and an increase in the expression of microglial purinergic receptor P2RY12 in brain tissues that we observed in DM mice treated with tPBM+insulin. The gene discussed is INS; the disease is diabetes mellitus.